Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05741333 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

In-Office Clinical Study of the Solo+ TTD

Study acronym: VENTY
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 1, 2026 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Jun 2027 to May 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Jun 2027 to Mar 2028
    • Site details revised at 7 of 7 sites
    v5
  2. Primary and study completion dates: Jun 2026 to Jun 2027
    • Study sites: 4 to 7
    v4
  3. Study sites: 2 to 4v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 2
    • Start date changed from estimate of Feb 2023 to Mar 30, 2023
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
AventaMed DAC
2 trials monitored
See 1 trial at risk
The objective of this study is to evaluate the safety and effectiveness of the Solo+ Tympanostomy Tube Device (Solo+ TTD) for the placement of tympanostomy tubes in paediatric patients undergoing a tympanostomy procedure.
Trial Details
NCT Number NCT05741333
Lead Sponsor AventaMed DAC
Conditions
(from sponsor)		 Ear Infection, Otitis Media
Related terms Otitis, Otitis Media
Enrollment 66 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov